Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Wyomissing, Pennsylvania Clinical Trials

A listing of Wyomissing, Pennsylvania clinical trials actively recruiting patient volunteers.

RESULTS

Found (7) clinical trials

Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry

This registry is a multi-center, prospective, observational registry, conducted in the United States and Europe. Some data may be collected retrospectively in patients currently implanted (implanted prior to enrollment) through the 12-month follow-up time frame. The CE-marked and FDA-approved Inspire system will be used within its intended use, allowing for …

Phase N/A

0.79 miles

Learn More »

The Effect of Guided Care With Vectra DA Compared to Treatment as Usual in Patients With Rheumatoid Arthritis

Disease activity in RA can be assessed by physical examination, patient-reported outcomes (PROs) or laboratory tests. Joints counts and PROs are partly or entirely subjective. Their ability to support clinical assessment is limited in certain settings, including for RA patients with common comorbidities, such fibromyalgia, obesity, or depression, or with …

Phase N/A

0.79 miles

Learn More »

Safety of Oral Anticoagulants Registry

Purpose and Rationale: Until recently, warfarin was the only oral anticoagulant (OAC) available in the US, and a substantial infrastructure has developed around its management. Over the past five years, four non-Vitamin-K antagonist oral anticoagulants (NOAC) have been approved by the FDA. The NOACs are associated with generally fewer and …

Phase N/A

1.15 miles

Learn More »

Molecular Genetics Studies of Cancer Patients and Their Relatives

PRIMARY OBJECTIVES: I. To identify rare cancer patients and families in whom the pattern of disease suggests a genetic susceptibility to cancer or other etiology suggestive of a carcinogenic exposure and to characterize the underlying predisposition. II. To determine the contribution of heredity (genotype) and biomarkers to clinical outcome (phenotype, …

Phase N/A

1.15 miles

Learn More »

Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy

The Impulse Dynamics OPTIMIZER Smart Pre-Market Application (PMA) clinical data confirmed that CCM therapy delivered with the Optimizer meaningfully improved health outcomes in patients with NYHA class III heart failure symptoms and left ventricular ejection fraction of 25-45%. CCM has shown significant improvements in quality of life measures, with an …

Phase N/A

1.17 miles

Learn More »

Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study

PRIMARY OBJECTIVES: I. The principal objective of the RESIN registry is to evaluate response to therapy using objective response criteria such as modified Response Evaluation Criteria in Solid Tumors (mRECIST) or European Association for Study of the Liver (EASL). The response criteria used will depend on tumor type treated and …

Phase N/A

2.06 miles

Learn More »

The National Myelodysplastic Syndromes (MDS) Study

Multi-center, prospective cohort study enrolling patients from centers in the National Cancer Institute (NCI) National Clinical Trials Network (NCTN) and NCI Community Oncology Research Program (NCORP). The accrual period is 5+ years. After central pathology review of registered participants, approximately 2,000 cases of MDS or MDS/MPN overlap disorders, and 500 …

Phase N/A

4.42 miles

Learn More »